Response theory for non-stationary ligand-receptor interaction and a solution to the growth signal firing problem

Journal of Theoretical Biology

Volumn 180, Issue 2, 1996, Pages 93-104

  Matsson, Leif ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; APE; ARTICLE; CELL CYCLE; CELL GROWTH; DNA REPLICATION; DOSE RESPONSE; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR OCCUPANCY; THEORY;

EID: 0030596416     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1996.0084     Document Type: Article

References (34)

1. AMIT, D. J. (1992). Modeling Brain Function. The World of Attractor Neural Networks, pp. 63-68. Cambridge: Cambridge University Press.
2. ARIENS, E. J. (1954). Affinity and intrinsic activity in the theory of competitive inhibition. I Problems and theory. Arch. Int. Pharmacodyn. 99, 32-49.
3. BARLOW, R. & BLAKE, J. F. (1989). Hill coefficients and the logistic equation. Trends Pharmacol. Sci. (Nov.) 10, 440-441.
4. BEVAN, J. A., ORIOWO, M. A. & BEVAN, R. D. (1986). Physiological Variation in α-Adrenoceptor-Mediated Arterial Sensitivity: Relation to Agonist Affinity. Science 234, 196-197.
5. BEVAN, J. A., BEVAN, R. D., KITE, K. & ORIOWO, M. A. (1988). Trends Pharmacol. Sci. 9, 87-89.
6. BINNEY, J. J., DOWRICK, N. J., FlSHER, A. J. & NEWMAN, M. E. J. (1992). The Theory of Critical Phenomena. An Introduction to the Renormalization Group, pp. 188-203. Oxford: Clarendon Press.
7. CANTRELL, D. A. & SMITH, K. A. (1984). The interleukin-2 T-cell system: A new cell growth model. Science 224, 1312-1316.
8. CLARK, A. J. (1926). The antagonism of acetylcholine by atropine. J. Physiol. 61, 547-556.
9. COLEMAN, S. (1985). Classical lumps and their quantum descendants, In: Aspects of Symmetry, Selected Erice Lectures, pp. 185-264. Cambridge: Cambridge University Press.
10. DASHEN, R. F., HASSLACHER, B. & NEVEU, A. (1974). Nonperturbative methods and extended-hadron models in field theory. II. Two-dimensional models and extended hadrons. Phys. Rev. D10, 4130-4138.
11. DE MEYTS, P. & ROUSSEAU, G. G. (1980). Receptor concepts. A century of evolution. Circ. Res. 46, (Suppl. I) 1.3-1.4.
12. FRÖHLICH, H. (1977). Long-Range Coherence in Biological Systems. Riv. Nuovo Cim. 7, 399-418.
13. FURCHGOTT, R. F. (1955). The pharmacology of vascular smooth muscle. Pharmac. Rev. 7, 183-265.
14. HILL, A. V. (1913). The combinations of Hemoglobin with Oxygen and with Carbon Monoxide. I. Biochem. J. 7, 471-480.
15. KENAKIN, T. P. (1989). Challenges for receptor theory as a tool for drug and drug receptor classification. Trends Pharmacol. Sci. (Jan.) 10, 18-22.
16. KRAMERS, H. A. & WANNIER, G. H. (1941). Statistics of the Two-Dimensional Ferro-magnet Part I: Phys. Rev. 60, 252-262.
17. KRAMERS, H. A. & WANNIER, G. H. (1941). Statistics of the Two-Dimensional Ferro-magnet Part II: see, 263-276.
18. LANGLEY, J. N. (1878). On the physiology of the salivary secretion. J. Physiol. 1, 339-369.
19. LANGLEY, J. N. (1905). On the reaction of cells and nerve endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and curari. J. Physiol. 33, 374-413.
20. LANGMUIR, I. (1918). The adsorption of gases on plane surfaces of glass, mica and platinum. J. Am. Chem. Soc. 40, 1361-1403.
21. LE BELLAC, M. (1991). Quantum and Statistical Field Theory. New York: Oxford University Press.
22. LIU, Y. & DILGER, J. P. (1993). Application of the one-and two-dimensional Ising models to studies of cooperativity between ion channels. Biophys. J. 64, 26-35.
23. MACKAY, D. (1988). Continuous variation of agonist affinity constants. Trends Pharmacol. Sci. 9, 156-157.
24. MARX, J. (1995). Cell Cycle Inhibitors May Help Brake Growth as Cells Develop. Science 267, 963-964.
25. MATSSON, L. (1993). Soliton growth-signal transduction in topologically quantized T cells. Phys. Rev. E48, 2217-2231.
26. MORSE, P. and FESHBACH, H. (1953). Methods of Mathematical Physics. New York: McGraw-Hill.
27. NICKERSON, M. (1956). Receptor occupancy and tissue response. Nature 178, 697-698.
28. ONSAGER, L. (1944). Crystal statistics I. A two-dimensional model with an order-disorder transition. Phys. Rev. 65, 117-149.
29. PATON, W. D. M. (1961). A theory of drug action based on the rate of drug-receptor combination. Proc. R. Soc. London Ser. B154, 21-69.
30. RUFFOLO JR., R. R. (1980). Review - Important Concepts of Receptor Theory. J. Auton. Pharmac. 2, 277-295.
31. SMITH, K. A. (1982). T-cell growth factor and glucocorticoids: Opposing regulatory hormones in neoplastic T-cell growth. Immunobiology 161, 157-173.
32. SMITH, K. A. (1989). The Interleukin 2 Receptor. Annu. Rev. Cell Biol. 5, 397-425.
33. STEPHENSON, R. P. (1956). A modification of receptor theory. Br. J. Pharmac. 11, 379-393.
34. WIEGEL, F. W. (1986). Introduction to Path-Integral Methods in Physics and Polymer Science, p. 3. Singapore: World Scientific.